Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation.
Loss of intracellular neuronal glutathione (GSH) is an important feature of neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The consequences of GSH depletion include increased oxidative damage to proteins, lipids, and DNA and subsequent cytotoxic effects. GSH is also an important modulator of cellular copper (Cu) homeostasis and altered Cu metabolism is central to the pathology of several neurodegenerative diseases. The cytotoxic effects of Cu in cells depleted of GSH are not well understood. We have previously reported that depletion of neuronal GSH levels results in cell death from trace levels of extracellular Cu due to elevated Cu(I)-mediated free radical production. In this study we further examined the molecular pathway of trace Cu toxicity in neurons and fibroblasts depleted of GSH. Treatment of primary cortical neurons or 3T3 fibroblasts with the glutathione synthetase inhibitor buthionine sulfoximine resulted in substantial loss of intracellular GSH and increased cytotoxicity. We found that both neurons and fibroblasts revealed increased expression and activation of p53 after depletion of GSH. The increased p53 activity was induced by extracellular trace Cu. Furthermore, we showed that in GSH-depleted cells, Cu induced an increase in oxidative stress resulting in DNA damage and activation of p53-dependent cell death. These findings may have important implications for neurodegenerative disorders that involve GSH depletion and aberrant Cu metabolism.
Du
Tai
T
Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.
Ciccotosto
Giuseppe D
GD
Cranston
Greg A
GA
Kocak
Gulcan
G
Masters
Colin L
CL
Crouch
Peter J
PJ
Cappai
Roberto
R
White
Anthony R
AR
D016475:3T3 Cells; D000818:Animals; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D016923:Cell Death / Q000502:physiology; D002540:Cerebral Cortex / Q000166:cytology; D003300:Copper / Q000378:metabolism*; D004249:DNA Damage; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005609:Free Radicals / Q000378:metabolism; D005786:Gene Expression Regulation; D005978:Glutathione / Q000172:deficiency; D005981:Glutathione Synthase / Q000037:antagonists & inhibitors; D051379:Mice; D019636:Neurodegenerative Diseases / Q000209:etiology / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
D004791:Enzyme Inhibitors; D005609:Free Radicals; D016159:Tumor Suppressor Protein p53; D019328:Buthionine Sulfoximine; D003300:Copper; D005981:Glutathione Synthase; D005978:Glutathione